Study of scalp ringworm in children
Part of Infections, Skin clinical trials.
This study looks at children with scalp ringworm (tinea capitis) to understand its features using clinical exams, dermoscopy, and lab tests. It may help improve diagnosis and treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a child between 1 and 18 years old.
- You must have scalp ringworm (a fungal infection of the scalp).
- You must not have used antifungal medications (cream, pills, or shampoo) in the past month.
- You must not have serious health conditions like liver, kidney, heart, autoimmune diseases, or cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the antifungal drug terbinafine works in children aged 2 to 18 who have tinea capitis (scalp ringworm). It aims to find the right dose to treat the infection effectively.
This trial compares taking itraconazole continuously versus in pulses (with breaks) to treat tinea capitis (a fungal scalp infection) in children. It aims to find which method works better and is safer.
This study is looking at hard-to-treat fungal skin infections to see what they look like under a microscope and under special skin imaging (dermoscopy). It may help find better ways to treat these stubborn infections.
This study tests a new type of injection treatment for stubborn ringworm (tinea) infections that haven't improved with standard pills or creams. It aims to see if this immunotherapy works better for hard-to-treat cases, especially when the fungus might be resistant to usual medicines.
This trial compares two oral medications, fluconazole and itraconazole, to see which works better for treating ringworm that hasn't cleared up with topical creams. If you've had ringworm for at least 6 months despite using antifungal creams, this study may help find a more effective treatment.
This study tests a special cream called TRIDERM D.S. on babies and toddlers (0 to 3 years old) with cradle cap or mild-to-moderate seborrheic dermatitis. The cream aims to normalize the skin and reduce flaking and redness, offering a gentle option for your child's skin.
Hear when a new Tinea Capitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.